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Abstract Objective: Corticosteroids have been applied via 
transtympanic route for a long time to treat the in-
ner ear disorders. A few animal models were used to 
answer the questions, “How much drug goes into the 
inner ear?” and “How far does the drug reach through 
the scala tympani and/or scala vestibuli?” However, 
the cerebrospinal fluid contamination poses a major 
problem. The aims of this study were to create a new 
sampling model showing the dexamethasone distri-
bution in the inner ear and to provide more reliable 
data about drug concentrations. 
Methods: Ten Hartley strain albino guinea pigs that 
weighted between 400 and 600 g were used. After 
dexamethasone application to the left ear, they were 
sacrificed at two time points: after 0.5 hours (Exp 1) 
and after 2 hours (Exp 2). The temporal bones were 
immediately dissected and put into liquid nitrogen for 
freezing. The apex, second turn, and basal turns of the 
cochlea and vestibule were separated, while the bone 
was in the frozen state. The samples were prepared 
and measured with ultraviolet (UV) spectroscopy.
Results: The total amount of dexamethasone was sta-
tistically higher in the left ear than the control ear. 
Although the basal turn and vestibule were the most 
prominent parts, there was no statistical difference 
between the different parts of the inner ear at 0.5 
hours. The vestibule and the apex showed the highest 
level of dexamethasone at 2 hours.
Conclusion: Although the model has some limita-
tions, it can measure dexamethasone concentrations 
and show the time variability in the inner ear. 
Keywords: Inner ear, cochlea, intratympanic injec-
tion, dexamethasone
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Corticosteroids have shown beneficial effects in 
many inner ear diseases, and potential mechanisms 
have been demonstrated in animal studies (1-3). 
Corticosteroids pass through the cell membrane 
and join with the specific receptor proteins in the 
nucleus and cytoplasm of the target cells. When 
higher concentrations of dexamethasone are tar-
geted in perilymph, very high drug doses have to 
be used systemically, which may cause serious side 
effects (1). Because of these side effects, intratym-
panic (IT) route is getting increasingly popular. 
Chandrasekhar et al. (4) have shown that dexa-
methasone applied intratympanicaly reaches much 
higher concentrations in perilymph than when ap-
plied intravenously. The experimental studies with 
immunohistochemical markers have shown that 4 
mg/mL dexamethasone administered via the IT 
route were connected intensively with the gluco-
corticoid receptors in the spiral ligament, organ of 
Corti, spiral ganglion, and vestibular epithelium 
(2, 3). 
The basic questions for the IT route are the fol-
lowing: “How much drug goes into the inner ear?” 
and “How far does the drug reach through the sca-
las?” Animal models were constructed to measure 
the amount of the drug and to find a distribution 
pattern in the inner ear after the IT administra-
tion. The fundamental problem was the sampling 
of perilymph. Single samples from the round win-
dow, oval window, and basal turn or sequential 
sampling from the apical region were attempted 
(4-6). They were able to show drug concentrations 
in the perilymph. But the major concern was the 
contamination of perilymph with the cerebrospi-
nal fluid (5). 
Further studies using markers and tissue-processing meth-
ods were also used to show the presence of drug in the certain 
regions of the inner ear (3). But they do not give any details 
regarding the drug concentration. Computer simulations have 
been developed based on the limited data for the estimation of 
drug amount in different parts of cochlea (7).
The aims of this study were to create a new sampling model 
showing the time-dependent dexamethasone distribution in the 
inner ear and to provide more reliable data about drug concen-
trations. 
Methods
Our study was conducted at Pamukkale University Center of 
Experimental Research. The permission was obtained from the 
Ethics Committee of Pamukkale University School of Medicine 
(Date: 08/Jan/2013; No: 2013/01). The institutional guidelines 
regarding animal experimentation were followed. 
In this study, 10 Hartley strain albino guinea pigs that weighted 
between 400 and 600 g were used. The guinea pigs were host-
ed in a controlled environment: 50% humidity and 16°C –21°C 
temperature. They were fed with special pellets and vitamin C 
(in the form of seasonal fresh fruits and vegetables). The room 
was illuminated following the 12-hour-light/dark cycle. We fol-
lowed the guidelines of animal care and use in accordance with 
the International Declaration of Helsinki.
Experiment Protocol: All procedures were performed under 
general anesthesia. General anesthesia was achieved by giving 
10 mg/kg xylazine HCl (Alfazyn 2%, Alfasan, the Woerden, 
Netherlands) and 75 mg/kg ketamine HCl (Ketan’s, Pfizer, İs-
tanbul, Turkey) together, intraperitoneally. With this dose, an-
esthesia lasted for 60-90 minutes. One-third of the initial dose 
of the same mixture was injected again if further anesthesia was 
needed. 
All guinea pigs underwent an otoscopic examination and had 
normal tympanic membranes. Dexamethasone (Dexoject, 4 mg/
mL; Mefar, İstanbul, Turkey) was applied to left ears of the guin-
ea pigs. Their right ears (nothing applied) were preserved as the 
control. On the scalp, a subcutaneous incision starting from the 
midline sagittal plan and combining orbital rim, extending to 
the vertebra was made. Periosteum was elevated, and temporal 
muscles, frontal, and parietal bones were observed. After tem-
poral muscles were elevated, temporal bone’s mastoid process 
and tympanic segment (bulla) were viewed. Bulla was drilled 
with a micro drill. Injections were applied via a 28- gauge needle 
(approximately 0.20 to 0.30 ml) until the bulla was filled. After 
injection, the guinea pig was put in the sideways position so that 
the left ear was on facing upwards. Then, the bulla was cleaned 
by aspirator and washed by saline at 0.5 hours. The experiment 
was terminated at two different time points: 0.5 hours (Exp 1) 
or 2 hours (Exp 2).
Dissection and Preparation: After drug application, the guinea 
pigs were divided into two groups according to the waiting time 
before sacrificing (0.5 hours, 2 hours). At the end of the speci-
fied time period, the guinea pigs were sacrificed using an intra-
cardiac potassium injection. After a large posterior incision, the 
soft tissue was removed. Temporal bones were separated from 
the skull by rough dissection. Then the squamous part, mastoid 
cortex, and tympanic bone were removed by micro rongeurs un-
der the operating microscope. The cochlea of the guinea pig is 
mainly in the mastoid cavity. The samples that were wrapped in 
aluminum foil were placed in a liquid nitrogen tank and were 
allowed to freeze for 5 minutes (Figure 1). The specimens in the 
frozen state were brought up. The cochlea was divided into three 
parts (the apex, second turn, and basal turn) with a scalpel under 
the operating microscope. The vestibule was then removed sep-
arately. To prevent contamination, the scalpel was replaced for 
each new piece. So, four samples were taken from each of the 
temporal bone. The samples were placed in an Eppendorf tube 
and stored at −5°C. 
Chemical Measurements: The samples were stored until the 
day of analysis at −5°C. All samples were weighted on the ana-
lytical balance before the analysis. The samples were transferred 
into sealed test tubes quickly, and 10 ml of distilled water was 
added to each tube. The bone and tissue fragments remained on 
the bottom of the tube. All the analyses were performed with 
the solution (tissue liquid) in the upper part.
Preparation of Calibration Samples for Dexamethasone: For 
calibration solution, 1 mL of solution including 4 mg/mL of 
dexamethasone (Dexoject) was taken. Stock solution was ob-
tained by diluting to 500 mL with distilled water. Respectively, 
1 mL, 3 mL, 5 mL, 8 mL, 12 mL, 16 mL, and 20 mL were 
taken from this solution, and each quantity was filled to 20 ml 
with distilled water. The solution concentration ppm values were 
calculated as, respectively, 8 ppm, 24 ppm, 40 ppm, 64 ppm, 
96 ppm, 128 ppm, and 160 ppm (ppm: a mg of substance in 
1 liter solution). Absorbance values of prepared samples were 
measured in Perkin Elmer Lambda 25 UV–VIS brand spectro-
photometer quartz tubes at 214 nm, 236 nm, and 240 nm, which 
showed maximum absorbance. These three obtained absorbance 
values were used to calculate the ppm values of the unknown 
samples. From the prepared calibration curve using the method 
of linear regression, equations that bound absorbance to concen-
tration were found separately for each wavelength. The formula 
obtained from the 240 nm wavelength was used because it gave 
the best results: A=(0.010xC)+0.016; where A=absorbance and 
C=concentration.  
The concentration value that corresponds to the absorbance val-
ue at 240 nm was calculated in ppm for dexamethasone. The 
Statistical Package for the Social Sciences (SPSS) version 18 
(SPSS Inc. Chicago, IL, USA) was used for statistical analysis. 
The Wilcoxon paired two-sample test was used to compare the 
groups. 
Results
Each experiment group consisted of 5 Hartley strain albino 
guinea pigs. The calculated average concentrations of the right 
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and left ears are plotted in Table 1. When we compared these 
averages, there was a statistically significant difference between 
the right and left ears in Exp 1, but there was no difference in 
Exp 2. 
Various drug concentrations in different parts of the inner ear 
are shown in Table 2. The drug distribution in Exp 1 and 2 is 
shown in Figures 2 and 3, as well. Although dexamethasone 
concentrations were higher in the basal turn and vestibule in 
Exp 1, there was no statistical difference among different parts 
of the inner ear. The lowest concentration was observed in the 
apex. There was also no statistically significant difference in Exp 
2, but the highest concentrations were found in the vestibule 
and apex. There was also a high amount of dexamethasone in 
the basal turn. Interestingly, we found a high dexamethasone 
concentration in the vestibule of the control ear after 2 hours.
Discussion
There are different kinds of sampling methods in the literature. 
Some authors obtained the samples directly from the round 
window. They aspirated a total of 10 µl perilymph from the scala 
tympani (4, 5). Others had an additional sample from the sca-
la vestibuli of the basal turn by drilling the bone (8, 9). Single 
sampling methods from the round window made us calculate 
only the concentration of the drug in the scala tympani (4, 5). 
The method did not lead us to estimate the distribution in the 
inner ear. The proposed solution for this problem was the use 
of markers and tissue-processing methods (3). After the IT 
application, the temporal bones were immunohistochemically 
stained for dexamethasone 21-phosphate, dexamethasone, and 
the glucocorticoid receptor. They found that the drug reached 
the cochlea in 15 minutes and the highest point at 1 hour. The 
spiral ligament, organ of Corti, spiral ganglion, and vestibular 
sensory epithelia were found to be positive (3). But this solu-
tion did not give detail regarding the concentration in different 
regions. Then the revolutionary apical sampling method was in-
troduced (10-12). They thought that taking small samples one 
by one from a hole drilled to the apical region of the cochlea 
minimized the cerebrospinal fluid contamination. All these 
methods have some weak sides, like dealing with the liquids. 
Liquids are easily transferred from one point to another and 
fill all the empty spaces easily. Also, molecules dissolved in the 
liquids tend to distribute evenly in all parts of the liquid and 
react to the changes quickly. Thus, sampling from one point of 
the inner ear will make the cerebrospinal fluid move to the in-
ner ear instantly. Then, dissolved molecules in perilymph have a 
new distribution, and the concentration of molecules changes. 
Plontke et al. (7, 13) used computer simulations to solve this 
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Figure 1. Frozen temporal bone of a guinea pig just before the 
dissection
Table 1. The average of all calculated values (ppm) was plotted according to groups’ different time points (Exp 1 [0.5 hours], Exp 2 [2 hours])
 Group n Mean±std Median (Min–Max) Significance
Exp 1 dex 5 25.1±13.39 19.59 (10.18–42.38) p=0.043
 control 5 6.37±4.7 5.69 (0–12.36) 
Exp 2 dex 5 24.31±29.68 9.8 (5.72–75.83) p=0.345
 control 5 13.04±13.05 12.98 (0–26.49) 
Dex: dexamethasone  
Table 2. Concentration values (ppm) of different inner ear parts. The left side of the table indicates the left ear (dexamethasone) and the right 
side the right ear (control) results
Dex Mean±Std Median (Min–Max) Median (Min–Max) Mean±Std Control
0.5 h basal 8±6.69 9.19 (0.08–16.87) 0.51 (0–5.7) 1.74±2.44 0.5 h basal
0.5 h 2.turn 3.57±3.74 1.61 (0.81–9.73) 1.9 (0–3.22) 1.67±1.48 0.5 h 2.turn
0.5 h apex 2.52±4.04 0.69 (0–9.53) 0 (0–1.62) 0.37±0.71 0.5 h apex
0.5 h vestibule 11.01±12.17 6.25 (2.85–32.37) 0 (0–11.56) 2.58±5.05 0.5 h vestibule
2 h basal 11.57±20.72 3.21 (0.27–48.5) 0.1 (0–8.45) 1.74±3.75 2 h basal
2 h 2.turn 2.17±3.41 0.51 (0–8.09) 0 (0–17.3) 4.3±7.49 2 h 2.turn
2 h apex 5.91±4.39 4.7 (1.24–11.09) 0.63 (0–3.53) 1.41±1.67 2 h apex
2 h vestibule 4.65±3.89 4.32 (0.1–9.32) 3.9 (0–19.3) 5.6±7.97 2 h vestibule
Dex: dexamethasone 
problem and to calculate drug amount throughout to cochlea. 
They reported that the mean basal-apical concentration gradient 
was calculated approximately as 17,000 by the finite element 
computer model (10). We tried to use the freezing method to 
overcome this situation. In our method, we cut the sections after 
freezing the inner ear. Thus, there was no liquid contamination. 
In all the methods, samples were taken from only one scala. Our 
model shows the total drug amount of the three scalas (tympa-
ni, media, and vestibuli). This is sometimes an advantage, and 
sometimes it is not. It changes according to required answers. 
Finding high concentrations in the basal region was consistent 
with other studies showing that cellular effects were more prom-
inent in the basal turn than in the apex of cochlea (14, 15). We 
also found dexamethasone in all parts of the inner ear. The basal 
turn and vestibule were found to have higher concentrations in 
a short time. But after two hours, the apex was the prominent 
instead of the basal turn, while vestibule preserved its concen-
tration. But our calculations did not match the concentration 
gradients calculated by Plontke et al. (7, 13) The question about 
the difference between the basal and apical region still remains.
Another issue considering the IT drug application was to deter-
mine how long the drug stays in the target region. Changes in 
the concentration were found at two hours in this study. But it is 
not clear what happens beyond that time. One of the limitations 
of our study was that the concentration calculations were not 
studied beyond two hours. It was demonstrated that IT dexa-
methasone passed to the inner ear in 15 minutes, reaching the 
highest levels at the first hour, and it disappeared completely in 
24 hours (3).
Another limitation to our study might be the diffusion of the 
drug through the bone of the otic capsule in guinea pigs. Miku-
lec et al. (16) applied gentamicin and the marker trimethylphe-
nylammonium using two different methods. First, they filled the 
bulla; second, they put the drugs limited to the round window 
only. They found that drug concentration increased more in the 
bulla group than in the round-window-only group (16). They 
concluded that some of the drug might have passed through the 
bony labyrinth. But in our study, in Exp 1, we found low values 
in the apical and the second turn region, and had the bone diffu-
sion been prominent, we would have found higher values.
The interesting part is that the control ear also showed slightly 
elevated drug levels in the vestibule after two hours. The most 
probable explanation for this situation is the contamination via 
Eustachian tube. 
In our study, we used the UV spectroscopy method. This technique 
is often used in chemical measurement, and the margin of error is 
very low. We could not obtain desired results in some guinea pigs 
clearly. The standardization of the samples and the amount of the 
drug absorbed by the tissues might be the source of error. 
Conclusion
In this preliminary study, a new animal model was established 
for analyzing the distribution and amount of the drug in the 
inner ear. We found that dexamethasone would reach the apical 
part of the cochlea in two hours, even in the case of 0.5 hour 
contact time on the round window. But the concentration was 
never as high as in the basal part of the cochlea. During two 
hours, the vestibule contained the drug constantly. Regardless of 
the limitations, different drugs can be used in this model before 
clinical applications. 
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Figure 3. Drug concentrations in the left ear in Exp 2 (2 hours)
Figure 2. Drug concentrations in the left ear in Exp 1 (0.5 hour)
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